| Literature DB >> 32088828 |
Yin Zhao1, Tamas Kiss2, Jordan DelFavero2, Lu Li3, Xing Li4,5, Lu Zheng4,5, Jie Wang6, Chao Jiang6, Jing Shi4,5, Zoltan Ungvari2, Anna Csiszar2, Xin A Zhang7.
Abstract
Aging is a crucial cause of cognitive decline and a major risk factor for Alzheimer's disease (AD); however, AD's underlying molecular mechanisms remain unclear. Recently, tetraspanins have emerged as important modulators of synaptic function and memory. We demonstrate that the level of tetraspanin CD82 is upregulated in the brains of AD patients and middle-aged mice. In young adult mice, injection of AAV-CD82 to the hippocampus induced AD-like cognitive deficits and impairments in neuronal spine density. CD82 overexpression increased TRPM7 α-kinase cleavage via caspase-3 activation and induced Numb phosphorylation at Thr346 and Ser348 residues. CD82 overexpression promoted beta-amyloid peptide (Aβ) secretion which could be reversed by Numb T346S348 mutants. Importantly, hippocampus-related memory functions were improved in Cd82-/- mice. Taken together, our findings provide the evidence that links the elevated CD82-TRPM7-Numb signaling to age-related cognitive impairment.Entities:
Keywords: Alzheimer’s disease; CD82; Memory; Numb; TRPM7 α-kinase
Year: 2020 PMID: 32088828 PMCID: PMC7205934 DOI: 10.1007/s11357-020-00166-4
Source DB: PubMed Journal: Geroscience ISSN: 2509-2723 Impact factor: 7.713